The Relationship between Family’s Assessment Support and MDR TB Patient’s Adherence on Treatment in RSUD Dr. Soetomo Surabaya

Safira Nur Ainiyah, Soedarsono Soedarsono, Pirlina Umiastuti

= http://dx.doi.org/10.20473/juxta.V10I22019.75-78
Abstract views = 75 times | views = 228 times

Abstract


Introduction: Multi Drug-Resistant Tuberculosis (MDR TB) is caused by Mycobacterium tuberculosis and has been resistant to isoniazid and rifampicin. Its treatment needs long time and causes some side effects which can make the patients non-adherent so that family support is needed. This study aims to know the relationship between family’s assessment support and MDR TB patient’s adherence on treatment in RSUD Dr. Soetomo Surabaya.

 

Methods: This was an analytic observational cross-sectional study, to know the frequency distribution of family’s assessment support, MDR TB patient’s adherence, and the relationship between them in 24 MDR TB patients, recruited from MDR TB Clinic, RSUD Dr. Soetomo, Surabaya, from October 2017 to June 2018 and their family. The analysis was descriptive statistic and inferential statistic using Fisher Exact Test.

 

Results: The results of this study showed that 83.3% of MDR TB patients’ family give high assessment support and 58.3% of MDR TB patients in RSUD Dr. Soetomo from October 2017 to June 2018 have high adherence on treatment. There is significant (p = 0.020), moderate (c = 0.468), and direct relationship between family’s assessment support and MDR TB patient’s adherence on treatment in RSUD Dr. Soetomo Surabaya.

 

Conclusion: To improve MDR TB patient’s adherence on treatment, family must give high assessment support.

Keywords


Family’s Assessment Support; MDR TB Patient; Adherence

Full Text:

PDF

References


Danusantoso H. Buku Saku Ilmu Penyakit Paru. 2nd ed. Jakarta: Penerbit Buku Kedokteran ECG, 2011.

Indonesia KKR. Tuberkulosis Temukan Obati Sampai Sembuh. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia, 2015.

Organization WH. Global Tuberculosis Report 2018. Geneva: World Health Organization, 2018.

Caminero J. Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. Paris: International Union Against Tuberculosis and Lung Disease, 2013.

Yuni IDAMM. Relationship Between TB Treatment Phase and Knowledge of MDR TB with TB Patient’s Compliance. 2017. 2017; 4: 12.

Prevention CfDCa. TB Elimination: Multidrug-Resistant Tuberculosis (MDR TB): (2012).

Organization WH. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva: World Health Organization, 2010.

Manalu HSP. Faktor-faktor yang Mempengaruhi Kejadian TB Paru dan Upaya Penanggulangannya. 2012.

Arbex MA, Varella Mde C, Siqueira HR and Mello FA. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2010; 36: 641-56.

Indonesia KKR. Petunjuk Teknis Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat. Jakarta: Kementerian Kesehatan Republik Indonesia, 2013.

Irnawati NM, Siagian IE and Ottay RI. Pengaruh Dukungan Keluarga terhadap Kepatuhan Minum Obat pada Penderita Tuberkulosis di Puskesmas Motoboi Kecil Kota Kotamobagu. Jurnal Kedokteran Komunitas dan Tropik. 2016; 4: 59-64.

Utami RS and Raudatussalamah R. Hubungan Dukungan Sosial Keluarga dengan Kepatuhan Berobat Penderita Hipertensi di Puskesmas Tualang. 2017. 2017; 12: 8.

Widyasrini ER, Probandari AN and Reviono. Factors Affecting the Success of Multi Drug Resistance (MDR-TB) Tuberculosis Treatment in Residential Surakarta. Journal of Epidemiology and Public Health. 2017; 2: 45-57.

Muna L and Soleha U. Motivasi dan Dukungan Sosial Keluarga Mempengaruhi Kepatuhan Berobat pada Pasien TB Paru di Poli Paru BP4 Pamekasan. Jurnal Ilmiah Kesehatan. 2014; 7: 172-9.

Kaulagekar-Nagarkar A, Dhake D and Jha P. Perspective of tuberculosis patients on family support and care in rural Maharashtra. The Indian journal of tuberculosis. 2012; 59: 224-30.

Morisky DE, Ang A, Krousel-Wood M and Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. Journal of clinical hypertension (Greenwich, Conn). 2008; 10: 348-54.

Xu M, Markstrom U, Lyu J and Xu L. Detection of Low Adherence in Rural Tuberculosis Patients in China: Application of Morisky Medication Adherence Scale. International journal of environmental research and public health. 2017; 14.

Karuniawati H, Ikawati Z and Gofir A. Pencegahan Sekunder untuk Menurunkan Kejadian Stroke Berulang pada Stroke Iskemik. Jurnal Manajemen dan Pelayanan Farmasi. 2015; 14: 14-21.

Saepudin, Padmasari S, Hidayanti P and Ningsih ES. Kepatuhan Penggunaan Obat pada Pasien Hipertensi di Puskesmas. Jurnal Farmasi Indonesia. 2013; 6: 246-53.

Chen B, Peng Y, Zhou L, et al. Social support received by multidrug-resistant tuberculosis patients and related factors: a cross-sectional study in Zhejiang Province, People's Republic of China. Patient preference and adherence. 2016; 10: 1063-70.


Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga

INDEXING BY:

     

 

Creative Commons License

This journal is licensed under Creative Commons Attribution-ShareAlike 4.0 International License 

 View JUXTA Stats